TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2025 Financial Results on August 14, 2025
TOMI Environmental Solutions (NASDAQ: TOMZ), a global decontamination and infection prevention company, has scheduled its Q2 2025 earnings conference call for August 14, 2025, at 4:30 p.m. ET. The company will release its financial results for the quarter ended June 30, 2025, after market close on the same day.
TOMI specializes in disinfection solutions through its proprietary Binary Ionization Technology® (BIT™) platform, which was developed under a DARPA defense grant. The technology uses ionized Hydrogen Peroxide (iHP™) and serves various sectors including hospitals, biosafety labs, pharmaceutical facilities, and commercial buildings.
TOMI Environmental Solutions (NASDAQ: TOMZ), azienda globale nel settore della decontaminazione e della prevenzione delle infezioni, ha programmato la conference call sui risultati del secondo trimestre 2025 per il 14 agosto 2025 alle 16:30 ET. La società pubblicherà i risultati finanziari relativi al trimestre chiuso il 30 giugno 2025 dopo la chiusura dei mercati nello stesso giorno.
TOMI è specializzata in soluzioni di disinfezione basate sulla sua piattaforma proprietaria Binary Ionization Technology® (BIT™), sviluppata con un finanziamento DARPA. La tecnologia utilizza perossido di idrogeno ionizzato (iHP™) e serve diversi settori, tra cui ospedali, laboratori di biosicurezza, strutture farmaceutiche e edifici commerciali.
TOMI Environmental Solutions (NASDAQ: TOMZ), empresa global de descontaminación y prevención de infecciones, ha programado su conference call de resultados del 2.º trimestre de 2025 para el 14 de agosto de 2025 a las 16:30 ET. La compañía publicará sus resultados financieros del trimestre cerrado el 30 de junio de 2025 tras el cierre del mercado ese mismo día.
TOMI se especializa en soluciones de desinfección mediante su plataforma propietaria Binary Ionization Technology® (BIT™), desarrollada con una subvención de defensa de la DARPA. La tecnología emplea peróxido de hidrógeno ionizado (iHP™) y atiende a sectores como hospitales, laboratorios de bioseguridad, instalaciones farmacéuticas y edificios comerciales.
TOMI Environmental Solutions (NASDAQ: TOMZ)는 글로벌 제독 및 감염 예방 기업으로, 2025년 2분기 실적 컨퍼런스 콜을 2025년 8월 14일 오후 4시 30분(동부시간, ET)에 예정했습니다. 회사는 같은 날 장 마감 후 2025년 6월 30일로 종료된 분기의 재무 실적을 발표할 예정입니다.
TOMI는 DARPA 국방 보조금으로 개발된 독자적 플랫폼 Binary Ionization Technology® (BIT™)를 통해 소독 솔루션을 전문으로 합니다. 이 기술은 이온화된 과산화수소(iHP™)를 활용하며 병원, 생물안전 연구소, 제약 시설 및 상업용 건물 등 다양한 분야에 적용됩니다.
TOMI Environmental Solutions (NASDAQ: TOMZ), entreprise mondiale de décontamination et de prévention des infections, a programmé sa conférence téléphonique sur les résultats du 2e trimestre 2025 pour le 14 août 2025 à 16h30 ET. La société publiera ses résultats financiers pour le trimestre clos le 30 juin 2025 après la clôture des marchés le même jour.
TOMI est spécialisée dans les solutions de désinfection via sa plateforme propriétaire Binary Ionization Technology® (BIT™), développée avec une subvention de défense de la DARPA. La technologie utilise du peroxyde d'hydrogène ionisé (iHP™) et s'adresse à divers secteurs, notamment les hôpitaux, les laboratoires de biosécurité, les installations pharmaceutiques et les immeubles commerciaux.
TOMI Environmental Solutions (NASDAQ: TOMZ), ein globales Unternehmen für Dekontamination und Infektionsprävention, hat seine Telefonkonferenz zu den Ergebnissen des zweiten Quartals 2025 für den 14. August 2025 um 16:30 Uhr ET angesetzt. Das Unternehmen wird die Finanzergebnisse für das am 30. Juni 2025 endende Quartal am selben Tag nach Börsenschluss veröffentlichen.
TOMI ist auf Desinfektionslösungen mittels seiner proprietären Plattform Binary Ionization Technology® (BIT™) spezialisiert, die im Rahmen eines DARPA-Förderprojekts entwickelt wurde. Die Technologie nutzt ionisiertes Wasserstoffperoxid (iHP™) und richtet sich an Bereiche wie Krankenhäuser, Biosicherheitslabore, pharmazeutische Einrichtungen und Geschäftsgebäude.
- None.
- None.
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the second quarter ended June 30, 2025, after the close of the financial markets on Thursday, August 14, 2025, and will hold a conference call at 4:30 p.m. ET that day.
To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time and provide participant access code 838858, or request the "TOMI Environmental Solutions second quarter earnings call." International callers please dial (973) 528-0011. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI website or register at the following link: https://www.webcaster4.com/Webcast/Page/2262/52861.
A replay of the teleconference will be available until Thursday, August 28, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use replay access code: 52861. A replay of the webcast will be available for at least 90 days on the company’s website, starting approximately one hour after the completion of the call.
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit www.steramist.com or contact us at info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements involve a number of risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond our control. As such, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Important factors that could affect our performance and cause results to differ materially from management’s expectations are described in the section entitled “Risk Factors,” in our Annual Report on Form 10-K and other SEC filings. These factors include: our history of losses that may prevent us from achieving profitability in the future; our lack of long-term customer contracts and our inability to rely on our sales history or backlog as an indicator of our future sales; that we are subject to a variety or risks associated with doing business internationally; our success in business depends on our ability to adequately protect our intellectual property; and that our stock price is volatile and there is a limited market for our shares. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
